NEW YORK (GenomeWeb) – Waters reported before the opening of the market on Tuesday that its second quarter revenues rose 7 percent year over year, thanks in large part to strong recurring revenues and sales in China, and the company's TA instruments business.

For the three months ended June 30, the company posted Q2 revenues of $596.2 million, up from $558.3 million in Q2 2017, but falling short of the average Wall Street estimate of $598.0 million. Foreign currency translation boosted revenues by 2 percent, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.